Dealmaking

Why IRRs for healthcare deals are better than the rest

The strong performance is a bit surprising given that more investors have jumped into healthcare deals, driving up multiples. However, the increased competition has not curbed investor appetites.

Silver Lake buys into Australian soccer leagues, Ares in talks to acquire ex-Coller execs’ secondaries shop

Ares Management is looking at a second acquisition of a secondaries firm this year.

Venture capital considers the metaverse

The metaverse has begun to attract investor interest, even as investors grapple with knowing what it is exactly.

Private Equity Jobs of the Week: NYS Teachers Retirement Fund, Brookfield and Morgan Stanley are hiring

This week’s jobs include a VP at Morgan Stanley, an assistant VP at NYS Teachers Retirement Fund and a private funds attorney at Brookfield.

Clearlake agrees to sell Proven Brands for ~$259m, Arcline founder talks about navigating inflation, supply chain challenges

Clearlake Capital agrees to sell Proven Brands to Hain Celestial Group for about $259 million.

Why SPACS are facing a reality check

The rise of blank cheque companies continued through 2021 before market fatigue and regulatory pushback triggered a fall off.

Rajeev Amara, founder of Arcline, on supply chain, inflation challenges

Amara spoke with Buyouts about what types of companies the firm is avoiding, and seeking, in the high-priced, inflationary environment.

SEC eyes stricter disclosure rules for SPACs; will next year be a sellers' bonanza?

Reforms may be coming around disclosure rules for SPACs.

GP stakes giant Blue Owl acquires Hong Kong placement firm

Ascentium founder and former Credit Suisse boss James Lee will become head of Blue Owl’s institutional sales team in Asia, per a statement seen exclusively by PEI.

PE dealmaking approaches record activity this year, Ten Coves leads funding in Cassini Systems

U.S. private equity deal-making to eclipse $1 trillion for the first time this year.